Cipla Medpro nabs $33M drug contract; Roche's subQ MabThera launch triggers Halozyme payment; Auxilium snaps up Canada's QLT;

@FiercePharma: Special: The top 5 vaccines by 2020. Report | Follow @FiercePharma

@TracyStaton: Here's @JohnCFierce's take on the Vertex VX-809/Kalydeco PhIII, including interview with CEO Jeff Leiden. Story | Follow @TracyStaton

@EricPFierce: Actavis says growing production at plant in Malta called for new warehouse. More | Follow @EricPFierce

@CarlyHFierce: Here's this week's issue of FierceVaccines. Hint: It's a good one. Issue | Follow @CarlyHFierce

> South Africa's government awarded Cipla Medpro a $32.6 million contract for respiratory drugs as part of an effort to cut deaths from asthma. Report

> Roche's ($RHHBY) European launch of MabThera in a subcutaneous form triggered at $5 million milestone payment to Halozyme ($HALO). Report

> Auxilium Pharmaceuticals ($AUXL) says it's buying the Canadian eye drug maker QLT to snag an experimental drug for retinal diseases. Report

> Actavis ($ACT) asked the FDA to approve its version of Acorda Therapeutics' ($ACOR) multiple sclerosis drug Ampyra; Acorda says it will defend its patent on the med. Report

> The FDA warned that popular over-the-counter acne products such as Proactiv can cause rare but serious and life-threatening allergic reactions. Report

> Amphastar Pharmaceuticals ($AMPH) said its initial public offering would be priced at $7 per share, which would yield about $56 million. Report

Medical Device News

@FierceMedDev: Check out our newest special report: Top 10 med tech R&D budgets. Read | Follow @FierceMedDev

@StacyALawrence: Newly public Inogen gains on FDA clearance for home oxygen device. Story | Follow @StacyALawrence

@MichaelGFierce: Intersect ENT files for $80M IPO to support steroid-delivering sinus implants. More via FierceDrugDelivery | Follow @MichaelGFierce

@EmilyWFierce: Ultrasound therapy outfit rakes in $2M for wearable chronic pain device. Story | Follow @EmilyWFierce

> Danaher demurs on M&A, looks to China, Brazil and Russia. Piece

> $125M IPO planned for former BMS medical imaging unit. News

Biotech News

@FierceBiotech: Polaris preps for a $400M fund to back a new wave of biotechs. More | Follow @FierceBiotech

@JohnCFierce: Biotech vets target $43M round to debut new antifungal venture. Story | Follow @JohnCFierce

@DamianFierce: We need to commission an inversion graphic for future stories. Article | Follow @DamianFierce

@EmilyMFierce: Gives a new meaning to YOLO: The Higgs Boson should have crushed the universe. More | Follow @EmilyMFierce

> Boehringer bags a 'breakthrough' tag for its Pradaxa antidote. Story

> Auxilium eyes a Canadian biotech for a tax-cutting merger. More

> FDA experts spurn AstraZeneca's pitch for ovarian cancer drug olaparib. Article

Vaccines News

> Italian officials probe Novartis for possible flu vaccine pricing fraud. Story

> FDA slaps Glaxo with warning letter for FluLaval plant. More

> CDC committee recommends AZ's FluMist over flu shot in children. Article

> The top 5 vaccines by 2020. Report

> Feds charge researcher in HIV vaccine fraud case. More

> Reuters: Sanofi plans to put dengue program into separate unit. News

Pharma Manufacturing News

> FDA finds contamination issues at GSK vax plant. More

> India production expert urges excellence from drugmakers. Story

> New Indian government looks to help small players finance upgrades. Article

> Sanofi buys Dubai's Globalpharma to produce generics in the Middle East. News

> Actavis opens $18M warehouse on Malta. Report

And Finally... Doctors should monitor more stroke patients for atrial fibrillation that may have gone undiagnosed. Report